Venture capital continued to flow in modest amounts to San Diego area biotechs last week…
Helixis Raises $5.5M | Xconomy
Nexus Biosystems Raises $5M | Xconomy
…while Arena with its potential obesity blockbuster Lorcaserin made $52.1M on a second stock offering. Arena shares closed nicely up on the day.
Arena Raises $52.1M in Offering | Xconomy
Meanwhile, in a bit of twisted unintentional sadism, one local firm can’t even generate enough shareholder interest to liquidate and close up shop.
